Health

U.S. FDA approves first generic version of Mylan's EpiPen


(Reuters) – The U.S. Food and Drug Administration on Thursday approved Teva Pharmaceutical Industries Ltd’s generic version of Mylan NV’s EpiPen for the emergency treatment of allergic reactions.

“Today’s approval of the first generic version of the most-widely prescribed epinephrine auto-injector in the U.S. is part of our longstanding commitment to advance access to lower cost, safe and effective generic alternatives once patents and other exclusivities no longer prevent approval,” FDA Commissioner Scott Gottlieb said.

Reporting by Ankur Banerjee in Bengaluru; Editing by Anil D’Silva



READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.